ATE357662T1 - Verfahren der pibf-konzentrationsbestimmung zur diagnose eines tumors in einem patienten - Google Patents

Verfahren der pibf-konzentrationsbestimmung zur diagnose eines tumors in einem patienten

Info

Publication number
ATE357662T1
ATE357662T1 AT01994744T AT01994744T ATE357662T1 AT E357662 T1 ATE357662 T1 AT E357662T1 AT 01994744 T AT01994744 T AT 01994744T AT 01994744 T AT01994744 T AT 01994744T AT E357662 T1 ATE357662 T1 AT E357662T1
Authority
AT
Austria
Prior art keywords
pibf
patient
tumor
diagnosis
concentration determination
Prior art date
Application number
AT01994744T
Other languages
English (en)
Inventor
Julia Szekeres-Bartho
Eszter Nagy
Beata Polgar
Tamas Palkovics
Margit Koch
Christoph Klade
Tamas Henics
Original Assignee
Intercell Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intercell Ag filed Critical Intercell Ag
Application granted granted Critical
Publication of ATE357662T1 publication Critical patent/ATE357662T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01994744T 2000-11-28 2001-11-28 Verfahren der pibf-konzentrationsbestimmung zur diagnose eines tumors in einem patienten ATE357662T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0199700A AT410753B (de) 2000-11-28 2000-11-28 Pibf für die diagnose von tumoren

Publications (1)

Publication Number Publication Date
ATE357662T1 true ATE357662T1 (de) 2007-04-15

Family

ID=3689570

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0199700A AT410753B (de) 2000-11-28 2000-11-28 Pibf für die diagnose von tumoren
AT01994744T ATE357662T1 (de) 2000-11-28 2001-11-28 Verfahren der pibf-konzentrationsbestimmung zur diagnose eines tumors in einem patienten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT0199700A AT410753B (de) 2000-11-28 2000-11-28 Pibf für die diagnose von tumoren

Country Status (9)

Country Link
US (1) US20040142394A1 (de)
EP (1) EP1337850B1 (de)
JP (2) JP4025645B2 (de)
AT (2) AT410753B (de)
AU (2) AU2002224901B2 (de)
CA (1) CA2431837A1 (de)
DE (1) DE60127442T2 (de)
ES (1) ES2283461T3 (de)
WO (1) WO2002044734A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATA8092002A (de) * 2002-05-28 2005-01-15 Intercell Ag Pibf
JP2015109806A (ja) * 2012-03-22 2015-06-18 アステラス製薬株式会社 新規ｒｅｔ融合体の検出法
GB201702392D0 (en) * 2017-02-14 2017-03-29 Univ Edinburgh Methods for cancer diagnosis using a gene expression signature
CN108447537A (zh) * 2018-03-23 2018-08-24 广西科技大学 一种妊娠期及哺乳期妇女用药安全和健康管理系统
KR102490714B1 (ko) * 2018-12-28 2023-01-26 재단법인 아산사회복지재단 Pibf 단백질을 유효성분으로 함유하는 염증성 질환 예방 또는 치료용 약학 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648340A (en) * 1991-10-31 1997-07-15 Barnea; Eytan R. Gestational agents for controlling cell proliferation
US5646003A (en) * 1994-03-23 1997-07-08 Barnea; Eytan R. Preimplantation factor
WO1999014372A1 (en) * 1997-09-15 1999-03-25 Abbott Laboratories Reagents and methods useful for detecting diseases of the urinary tract
AU4728299A (en) * 1998-07-02 2000-01-24 Envision Biomedical Consulting Antiproliferative and antiviral proteins and peptides
WO2001027633A1 (en) * 1999-10-08 2001-04-19 Envision Biomedical Consulting Gestational agents which modulate cell proliferation

Also Published As

Publication number Publication date
AT410753B (de) 2003-07-25
ES2283461T3 (es) 2007-11-01
US20040142394A1 (en) 2004-07-22
DE60127442D1 (de) 2007-05-03
ATA19972000A (de) 2002-12-15
JP2006230407A (ja) 2006-09-07
DE60127442T2 (de) 2007-11-29
EP1337850A1 (de) 2003-08-27
JP2004514909A (ja) 2004-05-20
AU2002224901B2 (en) 2006-11-09
WO2002044734A1 (en) 2002-06-06
CA2431837A1 (en) 2002-06-06
EP1337850B1 (de) 2007-03-21
JP4025645B2 (ja) 2007-12-26
AU2490102A (en) 2002-06-11

Similar Documents

Publication Publication Date Title
ATE289685T1 (de) Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
WO2019113525A3 (en) Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (tbi), using glial fibrillary acidic protein (gfap) and/or ubiquitin carboxy-terminal hydrolase l1 (uch-l1)
ATE516742T1 (de) Verfahren zur bestimmung der optischen eigenschaften eines mehrschichtigen gewebes
ATE519844T1 (de) Zusammensetzungen und verfahren zur erkennung, diagnose und therapie von hämatologischen malignomen
DE60126592D1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
DE60041355D1 (de) Verfahren zur detektion von erkrankungen
WO2006127861A3 (en) Diagnosis of diseases and conditions by analysis of histopathologically processed biological samples using liquid tissue preparations
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
DE602005021644D1 (de) Verfahren und reagentien zur diagnose von hantavirusinfektionen
FI20011664A7 (fi) Syöpäpesifiset oligoskkaridisekvenssit ja niiden käyttö
NO953770L (no) Analysemetode
ATE422671T1 (de) Verfahren zur diagnose von morbus alzheimer
Ntekrash et al. Assessment of complement cleavage in gingival fluid in humans with and without periodontal disease
DE50311309D1 (de) Vorrichtung und Verfahren zur Erfassung von Vorhofflimmern
ATE357662T1 (de) Verfahren der pibf-konzentrationsbestimmung zur diagnose eines tumors in einem patienten
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
ATE314648T1 (de) Diagnostisches verfahren für asthma
EP1476757A4 (de) Verfahren und kit zur krebsvorhersage
ATE272215T1 (de) Verfahren zur diagnose von sepsis unter bestimmung von ca 19-9
WO2005081783A3 (en) Method for determination and quantification of radiation or genotoxin exposure
EP2322209A3 (de) Tumorspezifische Oligosaccharid-Epitope und deren Verwendung
DE60221115D1 (de) Zusammensetzungen und verfahren zur verwendung von fibronektin-fragmenten bei krebsdiagnose
WO2005040806A3 (en) Use of protein asc as a marker for breast cancer
DE50313393D1 (de) Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1337850

Country of ref document: EP

REN Ceased due to non-payment of the annual fee